Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low vs Standard Bupivacaine Boluses for CACB in TKA
NCT06179628Completed
- Sponsor
- Chulalongkorn University
- Start
- Dec 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Average knee pain score assessed by Numerical rating scale (NRS). Started Dec 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06179628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06179628.